Medicare Enrolled
Dr. Jayalekshmy Kumar, M.D.
Neurology · Hopedale, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kumar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kumar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kumar
Dr. Jayalekshmy Kumar is a neurology specialist in Hopedale, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kumar performed 743 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kumar received a total of $21,255 from 83 pharmaceutical and/or device companies across 1131 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kumar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 20% volume in MA
$21,255 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗743
Medicare services
Top 20% in MA for neurology
Not available
Unique patients (not deduplicated)
$126
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
398 | $135 | $445 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
180 | $91 | $332 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
54 | $98 | $200 |
| New patient office visit, complex (60-74 min) | 40 | $172 | $634 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
35 | $52 | $930 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
18 | $363 | $1,977 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
18 | $174 | $900 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$21,255
Total received (2018-2024)
Avg $3,036/year across 7 years
Top 17% in MA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
83
Companies
1,131
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,404
2023
$4,204
2022
$3,563
2021
$2,418
2020
$1,561
2019
$2,751
2018
$2,355
Payments by company (2024)
ABBVIE INC.
$732
UCB, Inc.
$379
PFIZER INC.
$378
EMD Serono, Inc.
$281
Lundbeck LLC
$247
Lilly USA, LLC
$213
Amneal Pharmaceuticals LLC
$182
Merz Pharmaceuticals, LLC
$179
CSL Behring
$162
Teva Pharmaceuticals USA, Inc.
$161
Eisai Inc.
$151
Novartis Pharmaceuticals Corporation
$151
CATALYST PHARMACEUTICALS, INC.
$132
Alexion Pharmaceuticals, Inc.
$121
Mallinckrodt Hospital Products Inc.
$103
ANI Pharmaceuticals, Inc.
$97
SK Life Science, Inc.
$97
Biogen, Inc.
$73
Otsuka America Pharmaceutical, Inc.
$70
Inspire Medical Systems, Inc.
$60
Takeda Pharmaceuticals U.S.A., Inc.
$49
GENZYME CORPORATION
$48
Celgene Corporation
$48
Vanda Pharmaceuticals Inc.
$45
Kyowa Kirin, Inc.
$39
Genentech USA, Inc.
$28
Grifols USA, LLC
$28
Neurelis, Inc.
$25
InSightec,Inc
$23
Amgen Inc.
$23
TG Therapeutics, Inc.
$21
Kedrion Biopharma, Inc.
$21
Life Molecular Imaging Ltd
$20
Medtronic, Inc.
$15
Top 3 companies account for 33.8% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,564
Teva Pharmaceuticals USA, Inc.
$1,454
UCB, Inc.
$1,333
Novartis Pharmaceuticals Corporation
$1,169
Supernus Pharmaceuticals, Inc.
$1,021
Lundbeck LLC
$860
PFIZER INC.
$841
Biogen, Inc.
$830
EMD Serono, Inc.
$646
Sunovion Pharmaceuticals Inc.
$635
Amneal Pharmaceuticals LLC
$610
CSL Behring
$558
Lilly USA, LLC
$540
GENZYME CORPORATION
$539
SK Life Science, Inc.
$517
Eisai Inc.
$505
Biohaven Pharmaceutical Holding Company Ltd.
$445
Alexion Pharmaceuticals, Inc.
$432
Amgen Inc.
$409
Janssen Pharmaceuticals, Inc
$350
AbbVie Inc.
$297
EISAI INC.
$271
Mallinckrodt Enterprises LLC
$255
Acorda Therapeutics, Inc
$245
Allergan, Inc.
$240
ANI Pharmaceuticals, Inc.
$238
Genentech USA, Inc.
$236
Adamas Pharmaceuticals, Inc.
$219
Kyowa Kirin, Inc.
$214
Merz Pharmaceuticals, LLC
$207
Mallinckrodt Hospital Products Inc.
$205
Neurocrine Biosciences, Inc.
$197
IMPEL PHARMACEUTICALS INC.
$188
Celgene Corporation
$185
MDD US Operations, LLC
$165
US WorldMeds, LLC
$150
CATALYST PHARMACEUTICALS, INC.
$132
Neurelis, Inc.
$132
Avanir Pharmaceuticals, Inc.
$123
Bayer HealthCare Pharmaceuticals Inc.
$117
Allergan Inc.
$115
ACADIA Pharmaceuticals Inc
$105
Otsuka America Pharmaceutical, Inc.
$94
Takeda Pharmaceuticals U.S.A., Inc.
$81
ARBOR PHARMACEUTICALS, INC.
$80
LivaNova USA, Inc.
$76
Impax Laboratories, Inc.
$74
Alnylam Pharmaceuticals Inc.
$71
Biohaven Pharmaceuticals, Inc.
$71
Grifols USA, LLC
$64
IDORSIA PHARMACEUTICALS US INC
$63
Almatica Pharma LLC
$61
ASSERTIO THERAPEUTICS, Inc.
$60
Inspire Medical Systems, Inc.
$60
Mitsubishi Tanabe Pharma America, Inc.
$59
Zyla Life Sciences
$55
Upsher-Smith Laboratories LLC
$54
ARGENX US, INC.
$48
Balt USA, LLC
$48
Vanda Pharmaceuticals Inc.
$45
GE HEALTHCARE
$44
Life Molecular Imaging Ltd
$43
MITSUBISHI TANABE PHARMA AMERICA, INC.
$41
TG THERAPEUTICS, INC.
$38
Catalyst Pharmaceuticals, Inc.
$35
UPSHER-SMITH LABORATORIES LLC
$32
Assertio Therapeutics, Inc.
$32
Axsome Therapeutics, Inc.
$31
Harmony Biosciences LLC
$30
Greenwich Biosciences, Inc.
$25
GE HealthCare
$24
E.R. Squibb & Sons, L.L.C.
$24
InSightec,Inc
$23
TG Therapeutics, Inc.
$21
Kedrion Biopharma, Inc.
$21
Horizon Therapeutics plc
$20
Ethicon US, LLC
$20
Avion Pharmaceuticals
$16
JAZZ PHARMACEUTICALS INC.
$15
Medtronic, Inc.
$15
Bausch Health US, LLC
$15
Egalet US Inc
$14
Shire North American Group Inc
$13
Top 3 companies account for 20.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APLENZIN · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Albuked · Austedo XR · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COMIRNATY · COPAXONE · Cambia · DERMABOND · DUOPA · Dhivy · EMGALITY · EPIDIOLEX · Epidiolex · Exablate · FYCOMPA · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MYDAYIS · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OXTELLAR XR · Ocrevus · Optima Coil System · PAXLOVID · PERCEPT PC BRAINSENSE · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · REYVOW · RYTARY · Radicava · Rystiggo · SOLIRIS · SPRIX · Sunosi · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VYEPTI · VYVGART · Vimpat · Wakix · XADAGO · XARELTO · XCOPRI · Xadago · Xeomin · ZAVZPRET · ZEPOSIA · Zilbrysq · Zipsor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
200
County median income
$93,561
Nearest hospital to ZIP centroid (approximate)
MILFORD REGIONAL MEDICAL CENTER
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kumar is a clinical cardiology specialist, with above-average Medicare volume (top 20% in MA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kumar experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Kumar performed 398 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kumar receive payments from pharmaceutical companies?
Yes. Dr. Kumar received a total of $21,255 from 83 companies across 1,131 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kumar's costs compare to other neurologists in Hopedale?
Dr. Kumar's average Medicare payment per service is $126. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kumar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Hopedale
Browse neurologists in Hopedale ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MA
Which MA neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology